U.S. Physical Therapy Reports First Quarter 2015 Results

Company Declares $.15 Per Share Quarterly Dividend

HOUSTON--()--U.S. Physical Therapy, Inc. (NYSE: USPH), a national operator of outpatient physical therapy clinics, today reported results for the first quarter ended March 31, 2015.

U.S. Physical Therapy’s net income attributable to common shareholders prior to revaluation of redeemable non-controlling interests, net of tax (“operating results”) was $4.2 million for the first quarter of 2015 and for the first quarter of 2014. Diluted earnings per share from operating results were $.34 in the recent quarter as compared to $.35 in the comparable 2014 period. As noted in the Company’s press release on March 5, the unusually severe winter weather prevalent in many parts of the country during the first quarter adversely impacted operations. Management estimates that more than 20,000 patient visits were cancelled with an earnings impact of $.07 to $.09 per share.

First Quarter 2015 Compared to First Quarter 2014

  • Net revenues increased 10.7% from $69.8 million in the first quarter of 2014 to $77.2 million in the first quarter of 2015, due to an increase in total patient visits of 10.7% from 643,900 to 712,900 and a slight increase in the average net revenue per visit to $106.34 from $106.23. Net revenues from new clinics opened or acquired in the past 12 months was $6.2 million.
  • Total clinic operating costs were $60.4 million, or 78.2% of net revenues, in the first quarter of 2015, as compared to $53.1 million, or 76.1% of net revenues, in the 2014 period. The increase was primarily attributable to $5.5 million in operating costs of new clinics opened or acquired in the past 12 months. Total clinic salaries and related costs, including those from new clinics, were 55.7% of net revenues in the recent quarter versus 54.4% in the 2014 period. Rent, clinic supplies, contract labor and other costs as a percentage of net revenues were 21.1% for the recent quarter versus 20.4% in the 2014 period. The provision for doubtful accounts as a percentage of net revenues was 1.3% for the 2015 period and 1.4% in the 2014 period.
  • The gross margin for the first quarter of 2015 was $16.8 million or 21.8%, as compared to $16.6 million or 23.9% for the 2014 quarter.
  • Corporate office costs were $7.7 million in the first quarter of 2015 compared to $7.1 million in the 2014 first quarter. Corporate office costs were 9.9% of net revenues for the 2015 quarter compared to 10.2% of net revenues for the 2014 quarter.
  • Operating income for the recent quarter was $9.2 million compared to $9.5 million in the 2014 first quarter.
  • Interest expense was $0.3 million in the first quarter of 2015 and 2014.
  • The provision for income taxes for the 2015 period was $2.8 million and for the 2014 period $2.9 million. The provision for income taxes as a percentage of income before taxes less net income attributable to non-controlling interest was 40.0% in the 2015 first quarter and 41.0% in the 2014 first quarter.
  • Net income attributable to non-controlling interests was $2.0 million in the recent quarter as compared to $2.1 million in the year earlier period.
  • Operating results attributable to common shareholders for the three months ended March 31, 2015 and 2014 was consistent at $4.2 million for each period. Diluted earnings per share from operating results were $0.34 for the 2015 period and $0.35 for the 2014 period.
  • Same store visits increased 3.8% for de novo and acquired clinics open for one year or more and same store revenue increased 4.2% as the average net rate per visit increased by $.40.

Chris Reading, Chief Executive Officer, said, “This was undoubtedly a difficult quarter from a weather perspective yet there were a number of bright spots including solid same store visit growth, strong referral volume and a couple of acquisitions closed in the early part of this year. I continue to have great confidence in our team and in our collective ability to execute on our plan for 2015.”

Larry McAfee, Chief Financial Officer, noted, “By mid-March, after the winter storms subsided, the Company’s average daily patient visits rose significantly such that we ended the first quarter at a solid run rate. Absent the severe weather, patient visits in the first quarter would have been higher as same store patient referrals increased a strong 4.6%.”

U.S. Physical Therapy Declares Quarterly Dividend

The second quarterly dividend of 2015 for $.15 per share will be paid on June 5 to shareholders of record as of May 18.

First Quarter 2015 Conference Call

U.S. Physical Therapy's Management will host a conference call at 10:30 a.m. Eastern Time, 9:30 a.m. Central Time, on Thursday, May 7, 2015 to discuss the Company’s Quarter Ended March 31, 2015 results. Interested parties may participate in the call by dialing 1-888-335-5539 or 973-582-2857 and entering reservation number 22675485 approximately 10 minutes before the call is scheduled to begin. To listen to the live call via web-cast, go to the Company's website at www.usph.com at least 15 minutes early to register, download and install any necessary audio software. The conference call will be archived and can be accessed until July 7, 2015.

Forward-Looking Statements

This press release contains statements that are considered to be forward-looking within the meaning under Section 21E of the Securities Exchange Act of 1934, as amended. These statements contain forward-looking information relating to the financial condition, results of operations, plans, objectives, future performance and business of our Company. These statements (often using words such as “believes”, “expects”, “intends”, “plans”, “appear”, “should” and similar words) involve risks and uncertainties that could cause actual results to differ materially from those we expect. Included among such statements may be those relating to new clinics, availability of personnel and the reimbursement environment. The forward-looking statements are based on our current views and assumptions and actual results could differ materially from those anticipated in such forward-looking statements as a result of certain risks, uncertainties, and factors, which include, but are not limited to:

  • changes as the result of government enacted national healthcare reform;
  • changes in Medicare guidelines and reimbursement or failure of our clinics to maintain their Medicare certification status;
  • business and regulatory conditions including federal and state regulations;
  • governmental and other third party payor investigations and audits;
  • compliance with federal and state laws and regulations relating to the privacy of individually identifiable patient information, and associated fines and penalties for failure to comply;
  • changes in reimbursement rates or payment methods from third party payors including government agencies and deductibles and co-pays owed by patients;
  • transition to ICD-10 coding system;
  • revenue and earnings expectations;
  • general economic conditions;
  • availability and cost of qualified physical and occupational therapists;
  • personnel productivity;
  • competitive, economic or reimbursement conditions in our markets which may require us to reorganize or close certain operations and thereby incur losses and/or closure costs including the possible write-down or write-off of goodwill and other intangible assets;
  • acquisitions, purchase of non-controlling interests (minority interests) and the successful integration of the operations of the acquired businesses;
  • maintaining adequate internal controls;
  • availability, terms, and use of capital; and
  • weather and other seasonal factors.

Many factors are beyond our control. Given these uncertainties, you should not place undue reliance on our forward-looking statements. Please see our periodic reports filed with the Securities and Exchange Commission for more information on these factors. Our forward-looking statements represent our estimates and assumptions only as of the date of this press release. Except as required by law, we are under no obligation to update any forward-looking statement, regardless of the reason the statement is no longer applicable.

About U.S. Physical Therapy, Inc.

Founded in 1990, U.S. Physical Therapy, Inc. operates 497 outpatient physical and occupational therapy clinics in 42 states. The Company's clinics provide preventative and post-operative care for a variety of orthopedic-related disorders and sports-related injuries, treatment for neurologically-related injuries and rehabilitation of injured workers. In addition to owning and operating clinics, the Company manages 17 physical therapy facilities for third parties, including hospitals and physician groups.

More information about U.S. Physical Therapy, Inc. is available at www.usph.com. The information included on that website is not incorporated into this press release.

           

U.S. PHYSICAL THERAPY, INC. AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF NET INCOME
(IN THOUSANDS, EXCEPT PER SHARE DATA)
(unaudited)

 
Three Months Ended
March 31, 2015 March 31, 2014
Net patient revenues $ 75,807 $ 68,397
Other revenues   1,434     1,370  
Net revenues 77,241 69,767
Clinic operating costs:
Salaries and related costs 43,052 37,942
Rent, clinic supplies, contract labor and other 16,325 14,216
Provision for doubtful accounts 990 950
Closure costs   32     13  
Total clinic operating costs   60,399     53,121  
Gross margin 16,842 16,646
Corporate office costs   7,657     7,132  
Operating income 9,185 9,514
Interest and other income, net 8 1
Interest expense   (265 )   (253 )
Income before taxes 8,928 9,262
Provision for income taxes   2,777     2,939  
Net income including non-controlling interests 6,151 6,323
Less: net income attributable to non-controlling interests   (1,985 )   (2,095 )
Net income attributable to common shareholders $ 4,166   $ 4,228  
Basic earnings per share attributable to common shareholders:
From operations prior to revaluation of redeemable non-controlling interests, net of tax $ 0.34 $ 0.35
Charges to additional paid-in-capital - revaluation of redeemable non-controlling interests, net of tax   -     (0.08 )
Basic $ 0.34   $ 0.27  
 
Diluted earnings per share attributable to common shareholders:
From operations prior to revaluation of redeemable non-controlling interests, net of tax $ 0.34 $ 0.35
Charges to additional paid-in-capital - revaluation of redeemable non-controlling interests, net of tax   -     (0.08 )
Diluted $ 0.34   $ 0.27  
Shares used in computation:
Basic   12,313     12,129  
Diluted   12,313     12,144  
 
Dividends declared per common share $ 0.15   $ 0.12  

         

U.S. PHYSICAL THERAPY, INC AND SUBSIDIARIES

CONSOLIDATED EARNINGS PER SHARE

(IN THOUSANDS, EXCEPT PER SHARE DATA)

(unaudited)

 

Three Months Ended
March 31, 2015 March 31, 2014
Earnings attributable to common shareholders:
From operations prior to revaluation of redeemable non-controlling interests, net of tax $ 4,166 $ 4,228
Charges to additional paid-in-capital - revaluation of redeemable non-controlling interests, net of tax   -   (967 )
$ 4,166 $ 3,261  
Basic earnings per share attributable to common shareholders:
From operations prior to revaluation of redeemable non-controlling interests, net of tax $ 0.34 $ 0.35
Charges to additional paid-in-capital - revaluation of redeemable non-controlling interests, net of tax   -   (0.08 )
$ 0.34 $ 0.27  
Diluted earnings per share attributable to common shareholders:
From operations prior to revaluation of redeemable non-controlling interests, net of tax $ 0.34 $ 0.35
Charges to additional paid-in-capital - revaluation of redeemable non-controlling interests, net of tax   -   (0.08 )
$ 0.34 $ 0.27  
Shares used in computation:
Basic earnings per share - weighted-average shares 12,313 12,129
Effect of dilutive securities - stock options   -   15  

Denominator for diluted earnings per share - adjusted weighted-average shares

 

12,313   12,144  

           
U.S. PHYSICAL THERAPY, INC. AND SUBSIDIARIES
CONSOLIDATED BALANCE SHEETS
(IN THOUSANDS, EXCEPT SHARE DATA)
 
March 31, 2015 December 31, 2014
ASSETS (unaudited)
Current assets:
Cash and cash equivalents $ 14,557 $ 14,271
Patient accounts receivable, less allowance for doubtful accounts of $1,633 and $1,669, respectively 34,673 32,891
Accounts receivable - other, less allowance for doubtful accounts of $198 and $198, respectively 1,378 1,503
Other current assets   5,291     6,186  
Total current assets 55,899 54,851
Fixed assets:
Furniture and equipment 42,542 42,003

Leasehold improvements

  23,565     22,806  
66,107 64,809
Less accumulated depreciation and amortization   50,212     49,045  
15,895 15,764
Goodwill 159,176 147,914
Other intangible assets, net 24,537 24,907
Other assets   1,916     1,115  
$ 257,423   $ 244,551  
 
LIABILITIES AND SHAREHOLDERS' EQUITY
Current liabilities:
Accounts payable - trade $ 2,292 $ 1,782
Accrued expenses 18,178 22,839
Current portion of notes payable   932     883  
Total current liabilities 21,402 25,504
Notes payable 483 234
Revolving line of credit 41,500 34,500
Deferred rent 984 991
Other long-term liabilities   9,480     8,732  
Total liabilities 73,849 69,961
Commitments and contingencies
Redeemable non-controlling interests 7,373 7,376
Shareholders' equity:

U.S. Physical Therapy, Inc. shareholders' equity:

Preferred stock, $.01 par value, 500,000 shares authorized, no shares issued and outstanding - -
Common stock, $.01 par value, 20,000,000 shares authorized, 14,613,374 and 14,487,346 shares

issued, respectively

145 145
Additional paid-in capital 45,080 43,577
Retained earnings 136,491 134,186
Treasury stock at cost, 2,214,737 shares   (31,628 )   (31,628 )

Total U.S. Physical Therapy, Inc. shareholders' equity

150,088 146,280
Non-controlling interests   26,113     20,934  
Total equity   176,201     167,214  
$ 257,423   $ 244,551  

           
U.S. PHYSICAL THERAPY, INC. AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF CASH FLOWS
(IN THOUSANDS, EXCEPT PER SHARE DATA)
(unaudited)
 
Three Months Ended
March 31, 2015 March 31, 2014
OPERATING ACTIVITIES
Net income including non-controlling interests $ 6,151 $ 6,323
Adjustments to reconcile net income including non-controlling interests to net cash provided by operating activities:
Depreciation and amortization 1,807 1,387
Provision for doubtful accounts 991 950
Equity-based awards compensation expense 990 735
Loss on sale of business and sale or abandonment of assets, net 17 19
Excess tax benefit from shared-based compensation (271 ) (126 )
Deferred income tax 565 1,580
Write-off of goodwill - closed clinic 34 -
Changes in operating assets and liabilities:
Increase in patient accounts receivable (2,185 ) (3,002 )
Decrease in accounts receivable - other 125 146
Decrease in other assets 106 735
(Decrease) in accounts payable and accrued expenses (5,976 ) (5,241 )
Increase in other Long term liabilities   665     184  
Net cash provided by operating activities 3,019 3,690
INVESTING ACTIVITIES
Purchase of fixed assets (1,419 ) (849 )
Purchase of businesses, net of cash acquired (6,445 ) (125 )
Acquisitions of non-controlling interests (359 ) (2,833 )
Proceeds on sale of business and fixed assets, net   8     16  
Net cash used in investing activities (8,215 ) (3,791 )
FINANCING ACTIVITIES
Distributions to non-controlling interests (including redeemable non-controlling interests) (1,589 ) (1,413 )
Proceeds from revolving line of credit 34,000 29,000
Payments on revolving line of credit (27,000 ) (23,500 )
Payment of notes payable (200 ) (250 )
Tax benefit from share-based compensation 271 126
Other   -     1  
Net cash provided by financing activities 5,482 3,964
Net increase in cash and cash equivalents 286 3,863
Cash and cash equivalents - beginning of period   14,271     12,898  
Cash - end of period $ 14,557   $ 16,761  
SUPPLEMENTAL DISCLOSURES OF CASH FLOW INFORMATION
Cash paid during the period for:
Income taxes $ 1,275 $ 242
Interest $ 235 $ 345
Non-cash investing and financing transactions during the period:
Purchase of business - seller financing portion $ 500 $ -
Revaluation of redeemable non-controlling interests $ - $ 1,639

     
U.S. PHYSICAL THERAPY, INC. AND SUBSIDIARIES
RECAP OF CLINIC COUNT
 
Number
of
Date Clinics
 
March 31, 2014 472
June 30, 2014 486
September 30, 2014 489
December 31, 2014 489
 
March 31, 2015 494

Contacts

U.S. Physical Therapy, Inc.
Larry McAfee, (713) 297-7000
Chief Financial Officer
or
Chris Reading, (713) 297-7000
Chief Executive Officer
or
Westwicke Partners
Bob East, (443) 213-0502

Contacts

U.S. Physical Therapy, Inc.
Larry McAfee, (713) 297-7000
Chief Financial Officer
or
Chris Reading, (713) 297-7000
Chief Executive Officer
or
Westwicke Partners
Bob East, (443) 213-0502